申请人:Takeda Pharmaceutical Company Limited
公开号:US08318784B2
公开(公告)日:2012-11-27
The present invention provides a compound represented by the formula
which is useful as an agent for the prophylaxis or treatment of diseases related to the action of melatonin, or a salt thereof and the like.
本发明提供了一种化合物,其化学式表示为,该化合物可用作与褪黑激素作用相关的疾病的预防或治疗剂,或其盐等。